Craft

Omnicell

Stock Price

$40.1

2024-10-29

Market Capitalization

$1.8 B

2024-10-29

Revenue

$1.1 B

FY, 2023

Omnicell Summary

Company Summary

Overview
Omnicell is a provider of pharmacy and medication management solutions for the healthcare industry. It offers a central pharmacy dispensing service, that combines robotic technology, optimization software, and onsite and remote experts to automate operational aspects of the medication dispensing process. The company also delivers an automated dispensing system, a pharmacy carousel, an inventory optimization service, a central pharmacy blister packager, and other products.
Type
Public
Status
Active
Founded
1992
HQ
Fort Worth, TX, US | view all locations
Website
https://www.omnicell.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Randall Lipps

    Randall Lipps, Chairman, President, Chief Executive Officer, and Founder

  • Vicki MacDevitt
  • Giri Chodavarapu

    Giri Chodavarapu, Senior Vice President, Chief Information Officer

  • Diane Kaye

    Diane Kaye, Senior Vice President, Chief Product Officer

Operating MetricsView all

Backlog

$900K
50.0%

FY, 2022

Facility Space Leased, sq. ft.

596.3K
23.8%

FY, 2022

Hospitals Served

7K

FY, 2020

LocationsView all

18 locations detected

  • Fort Worth, TX HQ

    United States

    4220 North Fwy

  • Cranberry Township, PA

    United States

    500 Cranberry Woods Dr

  • Grapevine, TX

    United States

    1620 W Northwest Hwy STE 100

  • Milpitas, CA

    United States

    725 Sycamore Dr

  • Saint Petersburg, FL

    United States

    2003 Gandy Blvd N

  • Warrendale, PA

    United States

    51 Pennwood Pl #400

and 12 others

Omnicell Financials

Summary Financials

Revenue (Q3, 2024)
$282.4M
Gross profit (Q3, 2024)
$122.3M
Net income (Q3, 2024)
$8.6M
Cash (Q3, 2024)
$570.6M
EBIT (Q3, 2024)
$6.6M
Enterprise value
$1.9B

Footer menu